Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Rectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Squamous Cell Carcinoma of Head and Neck 6 Uterine Cervical Neoplasms 4 Small Cell Lung Carcinoma 4 Prostatic Neoplasms 4 Non-Muscle Invasive Bladder Neoplasms 4 Glioblastoma 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Neoplasms 3 Nasopharyngeal Carcinoma 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma 2 Adenocarcinoma 2 Spinal Cord Neoplasms 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Cancer Patients 1 Radiation Injuries 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pelvic Neoplasms 1

Interventions

trifluridine tipiracil drug combination 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × ESCC × Radiotherapy × Clear all

NCT07196345 2025-09-29

TAS-102 Plus Radiotherapy in Elderly ESCC

Qianfoshan Hospital

Phase 1/2 Not yet recruiting

ESCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡